Acron Past Earnings Performance
Past criteria checks 3/6
There is insufficient data on Acron's performance over the last few years.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Chemicals Industry Growth | 31.8% |
| Revenue growth rate | 53.6% |
| Return on equity | 51.6% |
| Net Margin | 34.1% |
| Last Earnings Update | 30 Sep 2021 |
Recent past performance updates
Recent updates
We Think Acron (MCX:AKRN) Can Stay On Top Of Its Debt
Feb 02
Shareholders Would Enjoy A Repeat Of Acron's (MCX:AKRN) Recent Growth In Returns
Dec 22A Look At The Fair Value Of Public Joint Stock Company Acron (MCX:AKRN)
Dec 01Is Acron (MCX:AKRN) A Risky Investment?
Oct 17Acron (MCX:AKRN) Is Reinvesting To Multiply In Value
Sep 10Calculating The Fair Value Of Public Joint Stock Company Acron (MCX:AKRN)
Aug 23Here's Why Acron (MCX:AKRN) Can Manage Its Debt Responsibly
Jun 11Acron's (MCX:AKRN) Returns On Capital Tell Us There Is Reason To Feel Uneasy
May 05What Kind Of Shareholders Own Public Joint Stock Company Acron (MCX:AKRN)?
Feb 22Are Dividend Investors Making A Mistake With Public Joint Stock Company Acron (MCX:AKRN)?
Jan 31
Returns On Capital At Acron (MCX:AKRN) Paint A Concerning Picture
Jan 11Did You Participate In Any Of Acron's (MCX:AKRN) Fantastic 143% Return ?
Dec 21Is Public Joint Stock Company Acron's (MCX:AKRN) 10% ROE Better Than Average?
Dec 03Revenue & Expenses BreakdownBeta
How Acron makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 21 | 170,991 | 58,232 | 33,768 | 0 |
| 30 Jun 21 | 149,414 | 33,926 | 34,064 | 0 |
| 31 Mar 21 | 130,737 | 24,038 | 31,450 | 0 |
| 31 Dec 20 | 119,864 | 3,310 | 29,822 | 0 |
| 30 Sep 20 | 111,308 | -2,805 | 31,040 | 0 |
| 30 Jun 20 | 110,795 | 6,097 | 30,056 | 0 |
| 31 Mar 20 | 113,410 | 5,360 | 28,865 | 0 |
| 31 Dec 19 | 114,835 | 24,219 | 29,254 | 0 |
| 30 Sep 19 | 119,898 | 28,227 | 28,705 | 0 |
| 30 Jun 19 | 119,121 | 26,409 | 27,660 | 0 |
| 31 Mar 19 | 113,516 | 16,612 | 26,831 | 0 |
| 31 Dec 18 | 108,062 | 12,768 | 25,190 | 0 |
| 30 Sep 18 | 102,832 | 10,825 | 23,087 | 0 |
| 30 Jun 18 | 96,866 | 14,951 | 21,596 | 0 |
| 31 Mar 18 | 94,319 | 16,715 | 20,365 | 0 |
| 31 Dec 17 | 94,342 | 13,432 | 20,438 | 0 |
| 30 Sep 17 | 91,863 | 13,644 | 19,466 | 0 |
| 30 Jun 17 | 89,383 | 7,434 | 20,034 | 0 |
| 31 Mar 17 | 88,417 | 14,980 | 19,482 | 0 |
| 31 Dec 16 | 89,359 | 27,778 | 19,263 | 0 |
| 30 Sep 16 | 90,089 | 25,941 | 19,050 | 0 |
| 30 Jun 16 | 94,012 | 25,556 | 17,690 | 0 |
| 31 Mar 16 | 89,381 | 23,412 | 16,864 | 0 |
| 31 Dec 15 | 92,019 | 15,908 | 16,479 | 0 |
Quality Earnings: AKRN has high quality earnings.
Growing Profit Margin: AKRN became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if AKRN's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: AKRN has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: AKRN has become profitable in the last year, making it difficult to compare its past year earnings growth to the Chemicals industry (144.9%).
Return on Equity
High ROE: AKRN's Return on Equity (51.6%) is considered outstanding.